The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tissue Heart Valves-Global Market Insights and Sales Trends 2024
Synopsis
Tissue or biological heart valve is made from animal tissue, such as porcine (pig) or bovine (cow), as it is similar to human tissue. Tissue heart valves need chemical treatment for protection and stent or frame for support. Tissue heart valves can last up to 10 to 20 years.
The global Tissue Heart Valves market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Heart Valves in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Tissue Heart Valves market. Stented Tissue Heart Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stentless Tissue Heart Valves segment is estimated at % CAGR for the next seven-year period.
The global tissue heart valves market is expected to grow substantially due to high prevalence of heart valve diseases, which is constantly rising due to socioeconomic factors, such as lifestyle-induced dietary, physical inactivity, and certain other habits, including smoking. Moreover, longer life expectancy of the geriatric population boosts the growth of the tissue heart valves market. As per a report of the National Institutes of Health (NIH), 8.5% of the world population is aged 65 or above, and it is anticipated to rise to nearly 17% by 2050. In addition, increase in demand for minimally invasive procedures and technological advancements are projected to propel the growth of the tissue heart valves market during the forecast period. On the other hand, stringent government approval process and high price of minimally invasive procedures are hindering the market growth. Nevertheless, huge unmet needs in the emerging markets and advanced treatment of valvular diseases are expected to create opportunities for the tissue heart valve market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tissue Heart Valves, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tissue Heart Valves market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tissue Heart Valves market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tissue Heart Valves sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tissue Heart Valves covered in this report include Edwards Lifesciences, Medtronic, Abbott, Abbott, Colibri Heart Valve, CryoLife and Labcor Laboratorios, etc.
The global Tissue Heart Valves market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edwards Lifesciences
Medtronic
Abbott
Abbott
Colibri Heart Valve
CryoLife
Labcor Laboratorios
Global Tissue Heart Valves market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tissue Heart Valves market, Segment by Type:
Stented Tissue Heart Valves
Stentless Tissue Heart Valves
Global Tissue Heart Valves market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tissue Heart Valves manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tissue Heart Valves in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Tissue or biological heart valve is made from animal tissue, such as porcine (pig) or bovine (cow), as it is similar to human tissue. Tissue heart valves need chemical treatment for protection and stent or frame for support. Tissue heart valves can last up to 10 to 20 years.
The global Tissue Heart Valves market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Heart Valves in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Tissue Heart Valves market. Stented Tissue Heart Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stentless Tissue Heart Valves segment is estimated at % CAGR for the next seven-year period.
The global tissue heart valves market is expected to grow substantially due to high prevalence of heart valve diseases, which is constantly rising due to socioeconomic factors, such as lifestyle-induced dietary, physical inactivity, and certain other habits, including smoking. Moreover, longer life expectancy of the geriatric population boosts the growth of the tissue heart valves market. As per a report of the National Institutes of Health (NIH), 8.5% of the world population is aged 65 or above, and it is anticipated to rise to nearly 17% by 2050. In addition, increase in demand for minimally invasive procedures and technological advancements are projected to propel the growth of the tissue heart valves market during the forecast period. On the other hand, stringent government approval process and high price of minimally invasive procedures are hindering the market growth. Nevertheless, huge unmet needs in the emerging markets and advanced treatment of valvular diseases are expected to create opportunities for the tissue heart valve market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tissue Heart Valves, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tissue Heart Valves market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tissue Heart Valves market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tissue Heart Valves sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tissue Heart Valves covered in this report include Edwards Lifesciences, Medtronic, Abbott, Abbott, Colibri Heart Valve, CryoLife and Labcor Laboratorios, etc.
The global Tissue Heart Valves market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edwards Lifesciences
Medtronic
Abbott
Abbott
Colibri Heart Valve
CryoLife
Labcor Laboratorios
Global Tissue Heart Valves market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tissue Heart Valves market, Segment by Type:
Stented Tissue Heart Valves
Stentless Tissue Heart Valves
Global Tissue Heart Valves market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tissue Heart Valves manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tissue Heart Valves in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Tissue Heart Valves Market Overview
1.1 Tissue Heart Valves Product Overview
1.2 Tissue Heart Valves Market Segment by Type
1.2.1 Stented Tissue Heart Valves
1.2.2 Stentless Tissue Heart Valves
1.3 Global Tissue Heart Valves Market Size by Type
1.3.1 Global Tissue Heart Valves Market Size Overview by Type (2018-2029)
1.3.2 Global Tissue Heart Valves Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tissue Heart Valves Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tissue Heart Valves Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tissue Heart Valves Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tissue Heart Valves Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tissue Heart Valves Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tissue Heart Valves Sales Breakdown by Type (2018-2023)
2 Global Tissue Heart Valves Market Competition by Company
2.1 Global Top Players by Tissue Heart Valves Sales (2018-2023)
2.2 Global Top Players by Tissue Heart Valves Revenue (2018-2023)
2.3 Global Top Players by Tissue Heart Valves Price (2018-2023)
2.4 Global Top Manufacturers Tissue Heart Valves Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tissue Heart Valves Market Competitive Situation and Trends
2.5.1 Tissue Heart Valves Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tissue Heart Valves Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tissue Heart Valves as of 2022)
2.7 Date of Key Manufacturers Enter into Tissue Heart Valves Market
2.8 Key Manufacturers Tissue Heart Valves Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tissue Heart Valves Status and Outlook by Region
3.1 Global Tissue Heart Valves Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tissue Heart Valves Historic Market Size by Region
3.2.1 Global Tissue Heart Valves Sales in Volume by Region (2018-2023)
3.2.2 Global Tissue Heart Valves Sales in Value by Region (2018-2023)
3.2.3 Global Tissue Heart Valves Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tissue Heart Valves Forecasted Market Size by Region
3.3.1 Global Tissue Heart Valves Sales in Volume by Region (2024-2029)
3.3.2 Global Tissue Heart Valves Sales in Value by Region (2024-2029)
3.3.3 Global Tissue Heart Valves Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tissue Heart Valves by Application
4.1 Tissue Heart Valves Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Tissue Heart Valves Market Size by Application
4.2.1 Global Tissue Heart Valves Market Size Overview by Application (2018-2029)
4.2.2 Global Tissue Heart Valves Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tissue Heart Valves Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tissue Heart Valves Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tissue Heart Valves Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tissue Heart Valves Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tissue Heart Valves Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tissue Heart Valves Sales Breakdown by Application (2018-2023)
5 North America Tissue Heart Valves by Country
5.1 North America Tissue Heart Valves Historic Market Size by Country
5.1.1 North America Tissue Heart Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tissue Heart Valves Sales in Volume by Country (2018-2023)
5.1.3 North America Tissue Heart Valves Sales in Value by Country (2018-2023)
5.2 North America Tissue Heart Valves Forecasted Market Size by Country
5.2.1 North America Tissue Heart Valves Sales in Volume by Country (2024-2029)
5.2.2 North America Tissue Heart Valves Sales in Value by Country (2024-2029)
6 Europe Tissue Heart Valves by Country
6.1 Europe Tissue Heart Valves Historic Market Size by Country
6.1.1 Europe Tissue Heart Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tissue Heart Valves Sales in Volume by Country (2018-2023)
6.1.3 Europe Tissue Heart Valves Sales in Value by Country (2018-2023)
6.2 Europe Tissue Heart Valves Forecasted Market Size by Country
6.2.1 Europe Tissue Heart Valves Sales in Volume by Country (2024-2029)
6.2.2 Europe Tissue Heart Valves Sales in Value by Country (2024-2029)
7 Asia-Pacific Tissue Heart Valves by Region
7.1 Asia-Pacific Tissue Heart Valves Historic Market Size by Region
7.1.1 Asia-Pacific Tissue Heart Valves Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tissue Heart Valves Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tissue Heart Valves Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tissue Heart Valves Forecasted Market Size by Region
7.2.1 Asia-Pacific Tissue Heart Valves Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tissue Heart Valves Sales in Value by Region (2024-2029)
8 Latin America Tissue Heart Valves by Country
8.1 Latin America Tissue Heart Valves Historic Market Size by Country
8.1.1 Latin America Tissue Heart Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tissue Heart Valves Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tissue Heart Valves Sales in Value by Country (2018-2023)
8.2 Latin America Tissue Heart Valves Forecasted Market Size by Country
8.2.1 Latin America Tissue Heart Valves Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tissue Heart Valves Sales in Value by Country (2024-2029)
9 Middle East and Africa Tissue Heart Valves by Country
9.1 Middle East and Africa Tissue Heart Valves Historic Market Size by Country
9.1.1 Middle East and Africa Tissue Heart Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tissue Heart Valves Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tissue Heart Valves Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tissue Heart Valves Forecasted Market Size by Country
9.2.1 Middle East and Africa Tissue Heart Valves Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tissue Heart Valves Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Edwards Lifesciences
10.1.1 Edwards Lifesciences Company Information
10.1.2 Edwards Lifesciences Introduction and Business Overview
10.1.3 Edwards Lifesciences Tissue Heart Valves Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Edwards Lifesciences Tissue Heart Valves Products Offered
10.1.5 Edwards Lifesciences Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Tissue Heart Valves Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Tissue Heart Valves Products Offered
10.2.5 Medtronic Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Tissue Heart Valves Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Tissue Heart Valves Products Offered
10.3.5 Abbott Recent Development
10.4 Abbott
10.4.1 Abbott Company Information
10.4.2 Abbott Introduction and Business Overview
10.4.3 Abbott Tissue Heart Valves Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abbott Tissue Heart Valves Products Offered
10.4.5 Abbott Recent Development
10.5 Colibri Heart Valve
10.5.1 Colibri Heart Valve Company Information
10.5.2 Colibri Heart Valve Introduction and Business Overview
10.5.3 Colibri Heart Valve Tissue Heart Valves Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Colibri Heart Valve Tissue Heart Valves Products Offered
10.5.5 Colibri Heart Valve Recent Development
10.6 CryoLife
10.6.1 CryoLife Company Information
10.6.2 CryoLife Introduction and Business Overview
10.6.3 CryoLife Tissue Heart Valves Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CryoLife Tissue Heart Valves Products Offered
10.6.5 CryoLife Recent Development
10.7 Labcor Laboratorios
10.7.1 Labcor Laboratorios Company Information
10.7.2 Labcor Laboratorios Introduction and Business Overview
10.7.3 Labcor Laboratorios Tissue Heart Valves Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Labcor Laboratorios Tissue Heart Valves Products Offered
10.7.5 Labcor Laboratorios Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tissue Heart Valves Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tissue Heart Valves Industrial Chain Analysis
11.4 Tissue Heart Valves Market Dynamics
11.4.1 Tissue Heart Valves Industry Trends
11.4.2 Tissue Heart Valves Market Drivers
11.4.3 Tissue Heart Valves Market Challenges
11.4.4 Tissue Heart Valves Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tissue Heart Valves Distributors
12.3 Tissue Heart Valves Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
